Insiders Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-22 pm EST			5-day change	1st Jan Change
273.44 ^USD	-0.50%		+1.67%	+4.91%

Jan. 17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT
Jan. 17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT

Insiders

Akari Therapeutics, plc Announces Board Changes	Dec. 18	CI
Amgen Names Howard Chang as Chief Scientific Officer	Nov. 20	DJ
Howard Chang Joins Amgen as Senior Vice President of Research and Chief Scientific Officer, Effective December 16, 2024	Nov. 20	CI
Collegium Pharmaceutical, Inc. Announces Chief Executive Officer Changes, Effective November 12, 2024	Nov. 07	CI
Carisma Therapeutics Announces Changes to Its Board of Directors	24-10-30	CI
Disc Medicine, Inc. Appoints Rahul Kaushik as Chief Technical Officer	24-10-23	CI
Mural Oncology plc Appoints Sachiyo Minegishi to its Board of Directors	24-09-23	CI
Tyra Biosciences Names Doug Warner Chief Medical Officer	24-09-10	MT
Geron Corporation Appoints Jim Ziegler as Executive Vice President, Chief Commercial Officer	24-09-08	CI
Lantheus Holdings, Inc. Appoints Julie Eastland as Board of Directors	24-09-05	CI
Amgen Inc. Appoints Anumita Tripathi as Director of Corporate Affairs for Amgen India	24-09-03	CI
Annexon, Inc. Announces Management Appointments	24-09-03	CI
Volcano Spring International Holdings Limited Announces Appointment of Zheng Jingwen as Non-Executive Director	24-09-02	CI
Genmab A/S Announces Executive Changes	24-08-16	CI
Gentian Diagnostics Appoints Matti Heinonen as Chief Executive Officer, Effective No Later Than February 2025	24-07-21	CI
Amgen Inc. Appoints Dr. Mary E. Klotman as Director	24-06-03	CI
Chimeric Therapeutics Appoints COO; Shares Rise 4%	24-05-01	MT
Abivax appoints new head of quality	24-02-07	CF
Madrigal Pharmaceuticals Names 3 New Executives	24-01-29	MT
Eaton Taps Olivier Leonetti as Finance Chief	24-01-17	DJ
Third Harmonic Bio Names Christopher Murphy as Chief Financial, Business Officer	24-01-04	MT
Amgen Names James Bradner as Chief Scientific Officer	23-12-14	MT
Amgen Inc. Announces Executive Changes	23-12-14	CI
Amgen Insider Sold Shares Worth $572,276, According to a Recent SEC Filing	23-12-05	MT
Insider Sell: Amgen	23-08-14	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Insiders

Filters